Company’s FlexASO programs targeting STATHMIN-2 and UNC13A showed three-fold potency, two-fold biodistribution improvement, improved safety, and greatly reduced off-target activity over standard ASOs QurAlis’ FlexASO™ Splice Modulator Platform designed to improve ASO performance, correct…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.